In addition, the mRNA expression levels of MMP-9 and uPA were significantly lower in DCIS-shCD44 xenograft tumors compared to those in DCIS-shLuc xenograft tumors (Fig. 5C). This evidence concerns the gene MMP9 and ductal breast carcinoma in situ.